Unique ID issued by UMIN | UMIN000045727 |
---|---|
Receipt number | R000052202 |
Scientific Title | A randomized, open-label, parallel-group study to evaluate the efficacy of dry chemical mopping in adults with mild to moderate atopic dermatitis. |
Date of disclosure of the study information | 2021/10/12 |
Last modified on | 2024/10/02 12:40:38 |
A randomized, open-label, parallel-group study to evaluate the efficacy of dry chemical mopping in adults with mild to moderate atopic dermatitis.
Cleaning Research
A randomized, open-label, parallel-group study to evaluate the efficacy of dry chemical mopping in adults with mild to moderate atopic dermatitis.
Cleaning Research
Japan |
Atopic dermatitis of mild to moderate severity
Dermatology |
Others
NO
To determine if the use of floor mops or vacuum cleaners for 24 weeks makes a difference in IgE, an indicator of atopic dermatitis-related problems.
Safety,Efficacy
Group differences in the change in IgE between the initial value and the 24th week of use.
The initial values for View Allergy39 will be the values on the day of the measurement selected for the study. View Allergy39 (only 18 items related to inhalation), TARC, eosinophils, and visual examination score at the dermatologist interview.
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Placebo
2
Prevention
Other |
Floor mop is used for 24 weeks
Vacuum cleaner is used for 24 weeks
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Men and women who are between 20 and 80 years old at the time of obtaining consent.
2) Those who are in charge of cleaning their homes, have a habit of cleaning with an electric vacuum cleaner, and are able to clean their homes early every morning.
3) Those who are able to come to the examination according to the set schedule.
4) Patients with mild to moderate atopic dermatitis who have stable symptoms (no change in medication, regardless of whether or not the patient has been to the hospital (to prevent changes in skin characteristics)). Patients with chronic diseases such as internal medicine that require regular visits to the hospital and treatment with oral medication will be included in the selection criteria, and changes in medication will be possible, although reporting will be required.
5) Those who have received sufficient explanation and written consent of their own free will to participate in this clinical study.
1) Persons who are active during the night and sleep during the day
2) Persons who are judged by the principal investigator or sub-investigator to be inappropriate as research subjects.
42
1st name | Koji |
Middle name | |
Last name | Habe |
Mie University Medical School Hospital / Mie University, Graduate School of Medicine
Dermatology
514-8507
2-174 Edobashi, Tsu, Mie 514-8507, Japan
059-232-1111
habe-k@clin.medic.mie-u.ac.jp
1st name | Koji |
Middle name | |
Last name | Umeda |
KSK Laboratories,Inc.
representative
514-0027
t.c.p 4F,7-15 Daimon, Tsu, Mie 514-0027, Japan
059-253-8091
info@ksk-lab.co.jp
Mie University, Graduate School of Medicine
matsuzaka co.,ltd
Profit organization
Research Ethics Review Committee, Department of Medicine, Mie University School of Medicine
2-174 Edobashi, Tsu, Mie 514-8507, Japan
059-231-5261
s-kikaku2@mo.medic.mie-u.ac.jp
NO
三重大学 総合研究棟2(三重県津市)
2021 | Year | 10 | Month | 12 | Day |
Unpublished
No longer recruiting
2021 | Year | 07 | Month | 15 | Day |
2021 | Year | 07 | Month | 21 | Day |
2023 | Year | 06 | Month | 01 | Day |
2025 | Year | 12 | Month | 31 | Day |
2026 | Year | 12 | Month | 31 | Day |
2021 | Year | 10 | Month | 12 | Day |
2024 | Year | 10 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052202